Epidermolysis Bullosa Eb clinical trials

Explore recruiting epidermolysis bullosa eb clinical trials.

Recruiting epidermolysis bullosa eb studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Epidermolysis Bullosa Eb trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double-blind, randomized, placebo-controlled, interventional, multicenter, phase III clinical trial to investigate the safety and efficacy of ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs) on epidermolysis bullosa (EB)

Austria, Hungary, Poland, Italy, Germany, Denmark +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Epidermolysis Bullosa Eb trials by city

Epidermolysis Bullosa Eb in Toronto Epidermolysis Bullosa Eb in Vancouver Epidermolysis Bullosa Eb in Montreal Epidermolysis Bullosa Eb in Calgary Epidermolysis Bullosa Eb in Edmonton Epidermolysis Bullosa Eb in Ottawa Epidermolysis Bullosa Eb in Winnipeg Epidermolysis Bullosa Eb in Quebec City Epidermolysis Bullosa Eb in Hamilton Epidermolysis Bullosa Eb in Kitchener Epidermolysis Bullosa Eb in London Epidermolysis Bullosa Eb in Halifax Epidermolysis Bullosa Eb in New York Epidermolysis Bullosa Eb in Los Angeles Epidermolysis Bullosa Eb in Chicago Epidermolysis Bullosa Eb in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease